Electronic Sepsis Screening Reduces 90-Day In-Hospital Mortality

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 17, 2024.

By Lori Solomon HealthDay Reporter

TUESDAY, Dec. 17, 2024 -- Electronic sepsis screening among hospitalized ward patients reduces 90-day in-hospital mortality compared with no screening, according to a study published online Dec. 10 in the Journal of the American Medical Association to coincide with the Critical Care Reviews Down Under meeting, held from Dec. 10 to 11 in Melbourne, Australia.

Yaseen M. Arabi, M.D., from King Abdulaziz Medical City in Riyadh, Saudi Arabia, and colleagues evaluated the effect of electronic sepsis screening compared to no screening on mortality among hospitalized ward patients. The analysis included data from 60,055 patients (29,442 in the screening group and 30,613 in the no-screening group) treated at five hospitals, with 45 wards (clusters) randomly assigned to nine sequences (five wards each, to have sepsis screening implemented at two-month periods).

The researchers found that alerts occurred in 14.6 percent in the screening group and 17.6 percent in the no-screening group. Compared with the no-screening group, within 12 hours of the alert, patients in the screening group were more likely to have serum lactate tested (adjusted relative risk [aRR], 1.30) and intravenous fluid ordered (aRR, 2.17). Electronic screening resulted in lower 90-day in-hospital mortality (aRR, 0.85). While screening reduced vasopressor therapy and multidrug-resistant organisms, it increased code blue activation, incident kidney replacement therapy, and Clostridioides difficile.

"The intervention is continuous, low-cost, reliable, reproducible, unbiased, and sustainable," the authors write.

One author reported a pending patent.

Abstract/Full Text

Editorial

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-12-18 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords